Platelet reactivity and cardiovascular events after percutaneous coronary intervention in patients with stable coronary artery disease: the Stent Thrombosis In Belgium (STIB) trial.

@article{Legrand2014PlateletRA,
  title={Platelet reactivity and cardiovascular events after percutaneous coronary intervention in patients with stable coronary artery disease: the Stent Thrombosis In Belgium (STIB) trial.},
  author={Victor L Legrand and Thomas Cuisset and Patrick Chenu and Mathy Vrolix and Christophe Martinez and Jo Andre Dens and Olivier Gach and Jean Boland and Marc J Claeys and Julien Magn{\'e} and Emanuele Barbato and William Wijns},
  journal={EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology},
  year={2014},
  volume={10 2},
  pages={204-11}
}
AIMS The Stent Thrombosis In Belgium (STIB) trial aimed to determine whether assessing platelet reactivity (PR) in patients with stable coronary artery disease undergoing elective percutaneous coronary intervention (PCI) could predict the risk of ischaemic complications and adverse clinical events up to 30 days post PCI. METHODS AND RESULTS PR before intervention was determined in 891 patients undergoing PCI for stable angina pectoris. Twelve to 24 hours before PCI, all patients received a… CONTINUE READING
4 Extracted Citations
32 Extracted References
Similar Papers

Referenced Papers

Publications referenced by this paper.
Showing 1-10 of 32 references

Similar Papers

Loading similar papers…